OncoGenex Pharmaceuticals is on the Cruelty Free Investing list for exploiting animals because the company does animal testing in discovery and development of some of their therapies.
The company stated in the following press release that they conduct pre-clinical trials of their drugs on animals.
“CSP-9222 has demonstrated anti-tumor activity in a range of pre clinical animal tumor models, including taxane-resistant tumors, following both intravenous and oral administration.” Read the following article
OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA. [Source: MarketWatch]
Company Website: http://oncogenex.com